Megan Boston - Net Worth and Insider Trading

Megan Boston Net Worth

The estimated net worth of Megan Boston is at least $229,454 dollars as of 2024-05-16. Megan Boston is the Executive Director of Benitec Biopharma Inc and owns about 25,927 shares of Benitec Biopharma Inc (BNTC) stock worth over $229,454. Details can be seen in Megan Boston's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Megan Boston has not made any transactions after 2023-08-11 and currently still holds the listed stock(s).

Transaction Summary of Megan Boston

To

Megan Boston Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Megan Boston owns 1 companies in total, including Benitec Biopharma Inc (BNTC) .

Click here to see the complete history of Megan Boston’s form 4 insider trades.

Insider Ownership Summary of Megan Boston

Ticker Comapny Transaction Date Type of Owner
BNTC Benitec Biopharma Inc 2023-08-11 director & Executive Director

Megan Boston Latest Holdings Summary

Megan Boston currently owns a total of 1 stock. Megan Boston owns 25,927 shares of Benitec Biopharma Inc (BNTC) as of August 11, 2023, with a value of $229,454.

Latest Holdings of Megan Boston

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BNTC Benitec Biopharma Inc 2023-08-11 25,927 8.85 229,454

Holding Weightings of Megan Boston


Megan Boston Form 4 Trading Tracker

According to the SEC Form 4 filings, Megan Boston has made a total of 1 transactions in Benitec Biopharma Inc (BNTC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Benitec Biopharma Inc is the acquisition of 25,907 shares on August 11, 2023, which cost Megan Boston around $72,799.

Insider Trading History of Megan Boston

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Megan Boston Trading Performance

GuruFocus tracks the stock performance after each of Megan Boston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Megan Boston is 21.71%. GuruFocus also compares Megan Boston's trading performance to market benchmark return within the same time period. The performance of stocks bought by Megan Boston within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Megan Boston's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Megan Boston

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.52
Relative Return to S&P 500(%) 13

Megan Boston Ownership Network

Ownership Network List of Megan Boston

No Data

Ownership Network Relation of Megan Boston


Megan Boston Owned Company Details

What does Benitec Biopharma Inc do?

Who are the key executives at Benitec Biopharma Inc?

Megan Boston is the director & Executive Director of Benitec Biopharma Inc. Other key executives at Benitec Biopharma Inc include 10 percent owner Steven Michael Oliveira , 10 percent owner Patrick Soon-shiong , and 10 percent owner California Capital Equity, Llc .

Benitec Biopharma Inc (BNTC) Insider Trades Summary

Over the past 18 months, Megan Boston made 1 insider transaction in Benitec Biopharma Inc (BNTC) with a net purchase of 25,907. Other recent insider transactions involving Benitec Biopharma Inc (BNTC) include a net purchase of 51,813 shares made by J Kevin Buchi ,

In summary, during the past 3 months, insiders sold 0 shares of Benitec Biopharma Inc (BNTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Benitec Biopharma Inc (BNTC) were sold and 77,720 shares were bought by its insiders, resulting in a net purchase of 77,720 shares.

Benitec Biopharma Inc (BNTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Benitec Biopharma Inc Insider Transactions

No Available Data

Megan Boston Mailing Address

Above is the net worth, insider trading, and ownership report for Megan Boston. You might contact Megan Boston via mailing address: Level 14, 114 William St, Melbourne, Vic C3 3000.

Discussions on Megan Boston

No discussions yet.